Insights from the Global Compliance Congress for Life Sciences

12.06.16 | By Kim Zoetbrood, Caroline Franco, Ruben Koolmees, Benoit Racault, Veronique Monjardet and Geert van Gansewinkel
The Third Annual Global Compliance Congress for Life Sciences took place November 16-17 in London. Polaris representatives attended the conference that addressed many important issues facing pharmaceutical, biotech and medical device Read more

Teva takes steps toward FCPA settlement

| By Amy Greenstein
On November 15, 2016 Teva announced that it is in “advanced discussions” with the DOJ and the SEC to settle investigations into alleged violations of the Foreign Corrupt Practices Act Read more